Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
Opioid use disorder increases risk for death from sepsis
Opioid use disorder increased the risk for death from sepsis, especially among young and healthy patients, according to findings presented at the Society of Critical Care Medicine’s Critical Care Congress.
Pharmacies targeted as opioid lawsuit enters new phase
Pharmacies are front and center as the second phase of a multidistrict lawsuit over the opioid crisis begins, a law professor told Healio Primary Care.
Log in or Sign up for Free to view tailored content for your specialty!
Medication-assisted therapy via telemedicine shows promise
A Boston-based start-up company that offers patients medication-assisted therapy through telemedicine is trying remove some of the stigma associated with opioid use disorder treatment.
Diagnosis detective: Discerning vasculitis from its many mimics
Clinicians who treat vasculitides are accustomed to uncertainty. Vasculitis, in its many forms, presents a laundry list of challenges, often leaving rheumatologists frustrated, if not stumped, at some point during diagnosis and management. But the challenges are not limited to vasculitis itself. An entire cross-section of conditions — from antiphospholipid syndrome to HIV to hematologic malignancies — can mimic vasculitis, prompting frequent misdiagnoses and potentially fatal treatment decisions.
Azar: HHS ‘should be very proud’ of its achievements, life expectancy among them
The past 3 years were marked by historic accomplishments that put HHS in a strong position to tackle the challenges that lie ahead, HHS Secretary Alex Azar II said at a speech to his employees Thursday.
Single-center study raises larger issues about proper billing
Two CMS codes for advanced care planning — 99497 and 99498 — were used less than 20 times at a tertiary care center in Iowa during in a nearly 3-year period, according to findings published in the Journal of the American Board of Family Medicine. Additionally, the center was successfully reimbursed only about one-quarter of the time, potentially resulting in lost revenues.
FDA, Federal Trade Commission to target 'anti-competitive' practices to support biosimilars
The FDA and the Federal Trade Commission on Monday announced a partnership aimed at supporting the adoption of biosimilars and interchangeable products by deterring what they called “anti-competitive business practices,” such as false or misleading promotions, according to a joint statement.
Just 1% of providers prescribed half of all opioid doses in 2017
In 2017, a mere 1% of providers were responsible for 49% of all opioid doses and 27% of opioid prescriptions in the United States, according to research published in BMJ.
Trump’s claim to have ‘saved’ preexisting conditions clashes with record
Earlier this month, health care policy suddenly managed to steal some headlines away from impeachment and the ongoing horserace of the 2020 Democratic presidential primary, when President Donald Trump declared in a tweet that he, “was the person who saved” protections for patients with preexisting conditions.
Refresh your practice
In this guest editorial, Wayne B. Jonas, MD, the executive director of Samueli Integrative Health Programs and a former director of the NIH’s Office of Alternative Medicine, discusses how to adapt your practice to a health care system that is quickly shifting away from the fee-for-service model and toward value-based care. He offers tips on billing in the new payment models, which require physicians to offer care to patients that extends beyond their immediate illness.
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read